DrugCite
Search

GAMMAGARD LIQUID

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Gammagard Liquid Adverse Events Reported to the FDA Over Time

How are Gammagard Liquid adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Gammagard Liquid, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Gammagard Liquid is flagged as the suspect drug causing the adverse event.

Most Common Gammagard Liquid Adverse Events Reported to the FDA

What are the most common Gammagard Liquid adverse events reported to the FDA?

Chills
447 (4.69%)
Pyrexia
353 (3.71%)
Headache
314 (3.3%)
Dyspnoea
279 (2.93%)
Nausea
252 (2.65%)
Urticaria
188 (1.97%)
Vomiting
154 (1.62%)
Hypersensitivity
143 (1.5%)
Tachycardia
137 (1.44%)
Malaise
134 (1.41%)
Back Pain
119 (1.25%)
Show More Show More
Erythema
119 (1.25%)
Rash
117 (1.23%)
Blood Pressure Increased
112 (1.18%)
Death
110 (1.15%)
Hypertension
106 (1.11%)
Haemolysis
98 (1.03%)
Pruritus
97 (1.02%)
Anaphylactic Reaction
93 (.98%)
Tremor
92 (.97%)
Fatigue
90 (.94%)
Meningitis Aseptic
88 (.92%)
Dizziness
83 (.87%)
Chest Pain
80 (.84%)
Hypotension
78 (.82%)
Cough
74 (.78%)
Cyanosis
74 (.78%)
Oxygen Saturation Decreased
73 (.77%)
Drug Intolerance
71 (.75%)
Diarrhoea
68 (.71%)
Flushing
61 (.64%)
Abdominal Pain
59 (.62%)
Anaphylactoid Reaction
56 (.59%)
Pneumonia
56 (.59%)
Pain In Extremity
54 (.57%)
Blood Pressure Decreased
53 (.56%)
Pulmonary Embolism
53 (.56%)
Anxiety
52 (.55%)
Condition Aggravated
52 (.55%)
Infusion Related Reaction
52 (.55%)
Pain
52 (.55%)
Neck Pain
50 (.52%)
Hyperhidrosis
49 (.51%)
Chest Discomfort
48 (.5%)
Hepatitis B
47 (.49%)
Hypoxia
47 (.49%)
Oedema Peripheral
47 (.49%)
Somnolence
46 (.48%)
Feeling Cold
44 (.46%)
Influenza Like Illness
44 (.46%)
Meningitis
44 (.46%)
Muscle Spasms
44 (.46%)
Abdominal Pain Upper
43 (.45%)
Body Temperature Increased
43 (.45%)
Haemolytic Anaemia
43 (.45%)
Convulsion
42 (.44%)
Drug Exposure During Pregnancy
42 (.44%)
Pallor
42 (.44%)
Anti-erythrocyte Antibody Positive
41 (.43%)
Musculoskeletal Stiffness
40 (.42%)
Anaphylactic Shock
39 (.41%)
Deep Vein Thrombosis
39 (.41%)
Asthenia
37 (.39%)
Respiratory Failure
37 (.39%)
Myalgia
36 (.38%)
Arthralgia
34 (.36%)
Blister
34 (.36%)
Dehydration
34 (.36%)
Haemoglobin Decreased
34 (.36%)
Paraesthesia
33 (.35%)
Drug Ineffective
32 (.34%)
Myocardial Infarction
32 (.34%)
Syncope
32 (.34%)
Feeling Abnormal
31 (.33%)
Heart Rate Increased
30 (.31%)
Musculoskeletal Pain
29 (.3%)
Sepsis
27 (.28%)
Wheezing
27 (.28%)
Hypoaesthesia
26 (.27%)
Livedo Reticularis
26 (.27%)
Loss Of Consciousness
25 (.26%)
Photophobia
25 (.26%)
Feeling Hot
24 (.25%)
Hepatitis B Antibody Positive
24 (.25%)
Vision Blurred
24 (.25%)
Cold Sweat
23 (.24%)
Off Label Use
23 (.24%)
Unresponsive To Stimuli
23 (.24%)
Lip Swelling
22 (.23%)
Sinusitis
22 (.23%)
Cardiac Failure Congestive
21 (.22%)
Thrombosis
21 (.22%)
Visual Impairment
21 (.22%)
Agitation
20 (.21%)
Herpes Zoster
20 (.21%)
Palpitations
20 (.21%)
Respiratory Tract Infection
20 (.21%)
Tachypnoea
20 (.21%)
Anaemia
19 (.2%)
Cerebrovascular Accident
19 (.2%)
Hot Flush
19 (.2%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Gammagard Liquid, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Gammagard Liquid is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Gammagard Liquid

What are the most common Gammagard Liquid adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Gammagard Liquid, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Gammagard Liquid is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Gammagard Liquid According to Those Reporting Adverse Events

Why are people taking Gammagard Liquid, according to those reporting adverse events to the FDA?

Off Label Use
345
Product Used For Unknown Indication
219
Hypogammaglobulinaemia
146
Immunodeficiency Common Variable
133
Primary Immunodeficiency Syndrome
124
Drug Use For Unknown Indication
124
Show More Show More
Chronic Inflammatory Demyelinating ...
88
Immunodeficiency
78
Myasthenia Gravis
63
Secondary Immunodeficiency
47
Multiple Sclerosis
47
Guillain-barre Syndrome
46
Idiopathic Thrombocytopenic Purpura
40
Multifocal Motor Neuropathy
31
Chronic Lymphocytic Leukaemia
28
Kawasakis Disease
28
Dementia Alzheimers Type
26
Blood Immunoglobulin G Decreased
21
Polyneuropathy
20
Dermatomyositis
20
Selective Igg Subclass Deficiency
20
Thrombocytopenia
19
Demyelinating Polyneuropathy
19
Polymyositis
15
Neuropathy Peripheral
15
Wegeners Granulomatosis
13
Immunoglobulin Therapy
13
Multiple Myeloma
11
Autoimmune Thrombocytopenia
10
Non-hodgkins Lymphoma
10
Sepsis
10
Infection
9
Combined Immunodeficiency
9
Myasthenic Syndrome
9
Autoimmune Disorder
9
Systemic Lupus Erythematosus
8
Bone Marrow Transplant
8
Blood Immunoglobulin A Decreased
8
Congenital Hypogammaglobulinaemia
7
Leukaemia
7
Intentional Drug Misuse
7
Immune System Disorder
7
Neutropenia
7
Drug Exposure During Pregnancy
7
Waldenstroms Macroglobulinaemia
7
Acute Lymphocytic Leukaemia
7
Selective Igm Immunodeficiency
6
Thrombocytopenia Neonatal
6
Chronic Obstructive Pulmonary Disea...
6
Rheumatoid Arthritis
6
Acute Myeloid Leukaemia
5

Drug Labels

LabelLabelerEffective
Gammagard LiquidBaxter Healthcare Corporation22-JUL-11

Gammagard Liquid Case Reports

What Gammagard Liquid safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Gammagard Liquid. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Gammagard Liquid.